Lessons Learned: Don’t assume the experts will be first to alert the public about drug safety issues. The FDA isn’t necessarily monitoring or acting promptly on adverse event reports. Likewise with drugmakers, and even the prescribing doctors. There’s every chance that a curious reporter or physician who is outside the specialty will unearth crucial information before the inside experts do.
